Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Hemorrhage × ulipristal acetate × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leiomyoma 2 Uterine Neoplasms 1 Uterine Hemorrhage 1 Pregnancy Complications 1 Infertility, Female 1

Interventions

asoprisnil 6 ulipristal acetate 1 relugolix 1 Mifepristone 1 High-Energy Shock Waves 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02147197 2019-04-30

A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

Allergan

Phase 3 Completed

157 enrolled 11 charts

Leiomyoma, Uterine Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡